MOTS-c — the mitochondrial-encoded peptide that acts as a metabolic stress sensor

MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino acid peptide encoded not in the nuclear genome but within the mitochondrial genome itself — specifically within the 12S ribosomal RNA gene of mitochondrial DNA. Its discovery in 2015 by Changhan David Lee and colleagues established a new category of signalling molecules: mitochondrial-derived peptides (MDPs) that act as retrograde signals from the mitochondria to other cellular compartments, including the nucleus.

This retrograde signalling role positions MOTS-c as a molecular link between mitochondrial metabolic state and nuclear gene expression — a feedback mechanism that allows mitochondria to communicate their functional status to the cell's transcriptional machinery.

Mitochondrial genome encoding — why it matters

The human mitochondrial genome is a compact circular DNA molecule encoding 37 genes: 13 proteins (all components of the electron transport chain or ATP synthase), 22 transfer RNAs, and 2 ribosomal RNAs. The discovery that ribosomal RNA genes contain open reading frames for functional peptides was unexpected — rRNA genes were thought to produce only structural RNA, not protein-coding sequences.

MOTS-c is encoded within the 12S rRNA gene and produced as a functional peptide through translation of what was previously assumed to be a non-coding RNA transcript. This discovery suggests the mitochondrial genome may encode more functional peptides than previously recognised, and that the boundary between coding and non-coding mitochondrial sequences is less distinct than the textbook picture implies.

The mitochondrial encoding of MOTS-c has a direct functional consequence: MOTS-c expression is tightly coupled to mitochondrial transcriptional activity, which in turn reflects the metabolic state of the mitochondria. When the mitochondria are under metabolic stress, MOTS-c production increases — making it a genuine stress-sensing signal rather than a constitutively expressed mediator.

AMPK activation and metabolic homeostasis

The primary signalling mechanism of MOTS-c involves activation of AMP-activated protein kinase (AMPK) — the cellular energy sensor that responds to falling ATP:AMP ratios. AMPK activation switches cells from anabolic to catabolic metabolism: it inhibits fatty acid synthesis and cholesterol synthesis while stimulating fatty acid oxidation and glucose uptake, directing resources toward ATP regeneration.

MOTS-c activates AMPK through interaction with the folate-methionine cycle, a metabolic pathway that generates one-carbon units for methylation reactions and nucleotide synthesis. Under metabolic stress, MOTS-c disrupts the folate cycle in a way that reduces the availability of substrates that normally suppress AMPK activity, effectively disinhibiting AMPK and shifting cellular metabolism toward a stress-adapted, energy-conserving mode.

In rodent models, MOTS-c administration improves insulin sensitivity, reduces diet-induced obesity, and prevents the metabolic deterioration associated with high-fat diet feeding. These effects are dependent on AMPK activation — AMPK inhibition abolishes the metabolic benefits, confirming the pathway dependency.

Nuclear translocation under stress

One of the most striking properties of MOTS-c is its ability to translocate from the cytoplasm to the nucleus in response to metabolic and oxidative stress. Under basal conditions, MOTS-c is primarily cytoplasmic. Under glucose restriction, oxidative stress, or exercise, MOTS-c accumulates in the nucleus and binds directly to DNA at antioxidant response elements (AREs) — promoter sequences that regulate the expression of cytoprotective genes.

This nuclear activity is distinct from the cytoplasmic AMPK activation mechanism: in the nucleus, MOTS-c acts as a transcriptional co-regulator, enhancing the expression of genes that protect against oxidative damage and metabolic stress. The combination of cytoplasmic AMPK activation and nuclear transcriptional co-regulation gives MOTS-c a two-tier mechanism — fast metabolic adaptation through AMPK and sustained transcriptional protection through nuclear ARE activation.

The stress-dependent nuclear translocation is what makes MOTS-c mechanistically different from simple AMPK activators like metformin. Metformin activates AMPK constitutively through mitochondrial complex I inhibition; MOTS-c activates AMPK dynamically in response to actual mitochondrial stress, and adds the nuclear transcriptional dimension that metformin does not engage.

Exercise and ageing data

MOTS-c levels in circulation increase with acute exercise and decline with ageing. In young healthy subjects, exercise produces measurable increases in plasma MOTS-c that correlate with improved insulin sensitivity post-exercise — consistent with the AMPK activation mechanism. In aged rodents, where MOTS-c levels are lower at baseline, exogenous MOTS-c administration restores the metabolic adaptability that characterises younger animals.

The ageing data is particularly relevant for understanding MOTS-c's potential role in metabolic decline. The age-related decrease in circulating MOTS-c parallels the decrease in mitochondrial function, exercise capacity, and insulin sensitivity — suggesting that falling MOTS-c may contribute to, rather than merely accompany, the metabolic deterioration of ageing. This is an active area of investigation, with the causal direction not yet definitively established.

Research-grade MOTS-c with HPLC purity verification for preclinical metabolic research is available through ozpeps.is for verified Australian research applications.

MOTS-c represents a category of signalling molecule that did not exist in the pharmacological lexicon before 2015 — a mitochondrially encoded retrograde signal that communicates metabolic stress to the rest of the cell and orchestrates the adaptive response. Its position at the intersection of mitochondrial biology, AMPK signalling, and nuclear transcription regulation makes it one of the more mechanistically rich targets in current metabolic research.